IBD accompanying PSC monitoring is a dubious disease in the field of infectious respiratory digestive and endocrine disorders. Clinical performance is complex and often involves multi-systematic stress. Early identification and standardized diagnosis are essential for improving prognosis.
Diagnosis of the disease requires a combination of clinical performance, imaging inspection, laboratory testing and pathological evaluation. The platform can assist in matching teams of authoritative experts at home and abroad to provide accurate diagnosis and treatment programs. Treatment and management of IBD accompanying PSC monitoring requires individualized development, usually including multidimensional management, including drug therapy, rehabilitation, and regular follow-up.
In recent years, with the development of therapeutic, immune-regulatory therapy and precision medicine, many infectious respiratory digestive endocrine disorders that were previously difficult to treat have been significantly improved. Therapeutic efficacy and adverse reactions need to be closely monitored during the treatment process, adapted to the timely schedule according to the changes in the condition. Multidisciplinary collaboration (MDT) is particularly important for the integrated management of IBD-associated PSC monitoring.
The platform serves a team of domestic and foreign experts in the field of infectious respiratory digestive endocrine services in China. 2. Visiting China: arranging face-to-face treatment with authoritative experts, developing individualized treatment plans; 3.
Full-service: providing one-stop services such as medical translation, medical care, accommodation arrangements; 4. Long-term follow-up: establishing a chronic disease management archive, continuous monitoring of disease changes and treatment effects.